BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 10825037)

  • 21. [Neisseria meningitidis. The pathophysiological role of lipopolysaccharides in association with meningococcal disease and septic shock].
    Pedersen MØ; Pedersen DS; Pedersen M; Penkowa M
    Ugeskr Laeger; 2008 Feb; 170(6):421-6. PubMed ID: 18252172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time- and fluid-sensitive resuscitation for hemodynamic support of children in septic shock: barriers to the implementation of the American College of Critical Care Medicine/Pediatric Advanced Life Support Guidelines in a pediatric intensive care unit in a developing world.
    Oliveira CF; Nogueira de Sá FR; Oliveira DS; Gottschald AF; Moura JD; Shibata AR; Troster EJ; Vaz FA; Carcillo JA
    Pediatr Emerg Care; 2008 Dec; 24(12):810-5. PubMed ID: 19050666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survivors of septic shock caused by Neisseria meningitidis in childhood: psychosocial outcomes in young adulthood.
    Vermunt LC; Buysse CM; Joosten KF; Duivenvoorden HJ; Hazelzet JA; Verhulst FC; Utens EM
    Pediatr Crit Care Med; 2011 Nov; 12(6):e302-9. PubMed ID: 21499180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality.
    Fijnvandraat K; Derkx B; Peters M; Bijlmer R; Sturk A; Prins MH; van Deventer SJ; ten Cate JW
    Thromb Haemost; 1995 Jan; 73(1):15-20. PubMed ID: 7740486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter evaluation of a human monoclonal antibody to Enterobacteriaceae common antigen in patients with Gram-negative sepsis.
    Albertson TE; Panacek EA; MacArthur RD; Johnson SB; Benjamin E; Matuschak GM; Zaloga G; Maki D; Silverstein J; Tobias JK; Haenftling K; Black G; Cowens JW;
    Crit Care Med; 2003 Feb; 31(2):419-27. PubMed ID: 12576946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies to endotoxin in the management of sepsis.
    Fang KC
    West J Med; 1993 Apr; 158(4):393-9. PubMed ID: 8317126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new prognostic scoring system for meningococcal septic shock in children. Comparison with three other scoring systems.
    Castellanos-Ortega A; Delgado-Rodríguez M; Llorca J; Sánchez Burón P; Mencía Bartolomé S; Soult Rubio A; Milano Manso G; Domínguez Sampedro P; Blanco Montero R; Rodríguez Núñez A; Zambrano Pérez E; Rey Galán C; López Negueruela N; Reig Sáenz R
    Intensive Care Med; 2002 Mar; 28(3):341-51. PubMed ID: 11904666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group.
    Levin M; Quint PA; Goldstein B; Barton P; Bradley JS; Shemie SD; Yeh T; Kim SS; Cafaro DP; Scannon PJ; Giroir BP
    Lancet; 2000 Sep; 356(9234):961-7. PubMed ID: 11041396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
    Sprong T; Pickkers P; Geurts-Moespot A; van der Ven-Jongekrijg J; Neeleman C; Knaup M; Leroy D; Calandra T; van der Meer JW; Sweep F; van Deuren M
    Shock; 2007 May; 27(5):482-7. PubMed ID: 17438452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapy of sepsis syndrome: a comparison of the available treatments.
    Fisher CJ; Bellingan G
    Klin Wochenschr; 1991; 69 Suppl 26():162-7. PubMed ID: 1813714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical aspects and outcome of meningococcal disease due to Neisseria meningitidis of serogroup W135 in 5 children].
    Faye A; Mariani-Kurkjian P; Taha MK; Louzeau C; Bingen E; Bourrillon A
    Arch Pediatr; 2005 Mar; 12(3):291-4. PubMed ID: 15734127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenal status in children with septic shock using low-dose stimulation test.
    Sarthi M; Lodha R; Vivekanandhan S; Arora NK
    Pediatr Crit Care Med; 2007 Jan; 8(1):23-8. PubMed ID: 17251878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity.
    Vermont CL; Hazelzet JA; de Kleijn ED; van den Dobbelsteen GP; de Groot R
    Crit Care; 2006 Feb; 10(1):R33. PubMed ID: 16507164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized, double-blind, placebo-controlled crossover pilot study of a potassium channel blocker in patients with septic shock.
    Warrillow S; Egi M; Bellomo R
    Crit Care Med; 2006 Apr; 34(4):980-5. PubMed ID: 16484892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of high doses of selenium, as sodium selenite, in septic shock patients a placebo-controlled, randomized, double-blind, multi-center phase II study--selenium and sepsis.
    Forceville X
    J Trace Elem Med Biol; 2007; 21 Suppl 1():62-5. PubMed ID: 18039501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of innate cytokine production capacity on clinical manifestation and severity of pediatric meningococcal disease.
    Sprong T; van der Ven-Jongekrijg J; Neeleman C; van der Meer JW; van Deuren M
    Crit Care Med; 2009 Oct; 37(10):2812-8. PubMed ID: 19707127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous low-dose infusion of terlipressin as a rescue therapy in meningococcal septic shock.
    Michel F; Thomachot L; David M; Nicaise C; Vialet R; Di Marco JN; Lagier P; Martin C
    Am J Emerg Med; 2007 Sep; 25(7):863.e1-2. PubMed ID: 17870513
    [No Abstract]   [Full Text] [Related]  

  • 39. HA-1A in septic patients with ARDS: results from the pivotal trial.
    Bigatello LM; Greene RE; Sprung CL; Panacek EA; Straube RC; Zimmerman JL; Maunder RJ; Lanken PN; Pile-Spellmann E; Stanek KS
    Intensive Care Med; 1994 May; 20(5):328-34. PubMed ID: 7930026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of systemic and renal effects of dopexamine and dopamine in norepinephrine-treated septic shock.
    Schmoelz M; Schelling G; Dunker M; Irlbeck M
    J Cardiothorac Vasc Anesth; 2006 Apr; 20(2):173-8. PubMed ID: 16616656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.